Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2010 - 11 - 04

Press Release Menarini L'Aquila

Sixty-seven (67) million units produced last year* compared to 62 million manufactured* before the earthquake.

A record number for the Menarini L' Aquila production site.
In fact, after the April 6th, 2009 earthquake, that hit both the city and the production site, the L’Aquila production plant has reached its highest production level ever since its opening in 1993.
Such an accomplishment has been made possible thanks to a special synergy between the steadfast will of the plant’s employees, and their determination to start up again after the tragic events of 2009, and the strong confidence that the company has placed in the L'Aquila production site, confirmed by the substantial investments made during the months following the earthquake and, more recently, a further investment of 2 million Euro for process equipment, which has brought, and will bring in future, a boost to production.

"SWe are proud to have continued investing in the territory of L'Aquila, in which we strongly believe. The city and its inhabitants have shown the world what it means to be resolute and muster up the will to start over, and we are proud of the fact that, thanks to this spirit, we have been able to increase our production capacity, reaching goals of the highest quality and of the highest international standards"
commented Carlo Colombini, General Manager of Manufacturing for the Menarini Group.

"The municipal administration" - declared Mayor of L’Aquila, Massimo Cialente - wishes to express its deep satisfaction at the significant results achieved by the Menarini L’Aquila plant, a site which is increasingly recognised as a centre of excellence on a national level. The company, which plays a major role in the pharmaceutical sector, has decided to make significant investments in the L'Aquila site, thus providing a decisive contribution towards the rebuilding of the capital city of the Abruzzo region after the tragic earthquake of 6th April, 2009. The company has indeed demonstrated its desire to not only re-establish the production level accomplished before the earthquake, but to increase it even further. This has been an important gesture made by the Menarini Group and one which has allowed us, the L’Aquila community, and its economy, both of which have been tried by recent events, to look to the future with renewed confidence."

*October 2009 - September 2010 (pharmaceutical production of over 1 billion units in tablets and capsules)

*April 2008 - March 2009

Florence, November 4th, 2010